Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith L Davis

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
Advances in Hematology|December 5, 2015
Real-World Assessment of Clinical Outcomes in Patients with Lower-Risk Myelofibrosis Receiving Treatment with RuxolitinibKeith L Davis, Isabelle Côté, James A Kaye, et al.
Cancer Medicine|May 31, 2019
Treatment patterns, adverse events, and economic burden in a privately insured population of patients with chronic lymphocytic leukemia in the United StatesShaum M Kabadi, Ravi K Goyal, Saurabh P Nagar, et al.
Lung Cancer (Amsterdam, Netherlands)|December 24, 2014
Real-world treatment patterns and costs in a US Medicare population with metastatic squamous non-small cell lung cancerKeith L Davis, Ravi K Goyal, Stephen L Able, et al.
Advances in Hematology|March 7, 2019
Real-World Treatment Patterns, Outcomes, and Healthcare Resource Utilization in Relapsed or Refractory Multiple Myeloma: Evidence from a Medical Record Review in FranceHuamao Mark Lin, Keith L Davis, James A Kaye, et al.
Journal of Studies on Alcohol|January 28, 2004
The costs of screening and brief intervention for risky alcohol useGary A Zarkin, Jeremy W Bray, Keith L Davis, et al.
Cancer Medicine|March 18, 2021
Overall survival, adverse events, and economic burden in patients with chronic lymphocytic leukemia receiving systemic therapy: Real-world evidence from the medicare populationRavi K Goyal, Saurabh P Nagar, Shaum M Kabadi, et al.
Clinical Breast Cancer|May 21, 2019
Treatment Patterns and Outcomes Associated With Palbociclib Plus Letrozole for Postmenopausal Women With HR<sup>+</sup>/HER2<sup>-</sup> Advanced Breast Cancer Enrolled in an Expanded Access ProgramAdam Brufsky, Debanjali Mitra, Keith L Davis, et al.
The Journal of Behavioral Health Services & Research|July 13, 2005
Mental health and substance abuse treatment utilization among individuals served by multiple public agencies in 3 statesJeremy W Bray, Keith L Davis, Linda Graver, et al.
BMC Health Services Research|November 14, 2014
Comparison of demographics, treatment patterns, health care utilization, and costs among elderly patients with extensive-stage small cell and metastatic non-small cell lung cancersSudeep J Karve, Gregory L Price, Keith L Davis, et al.
Medical Care|January 17, 2007
The effect of screening and brief intervention for risky drinking on health care utilization in managed care organizationsJeremy W Bray, Gary A Zarkin, Keith L Davis, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Advances in Hematology|December 5, 2015
Real-World Assessment of Clinical Outcomes in Patients with Lower-Risk Myelofibrosis Receiving Treatment with RuxolitinibKeith L Davis, Isabelle Côté, James A Kaye, et al.
Cancer Medicine|May 31, 2019
Treatment patterns, adverse events, and economic burden in a privately insured population of patients with chronic lymphocytic leukemia in the United StatesShaum M Kabadi, Ravi K Goyal, Saurabh P Nagar, et al.
Lung Cancer (Amsterdam, Netherlands)|December 24, 2014
Real-world treatment patterns and costs in a US Medicare population with metastatic squamous non-small cell lung cancerKeith L Davis, Ravi K Goyal, Stephen L Able, et al.
Advances in Hematology|March 7, 2019
Real-World Treatment Patterns, Outcomes, and Healthcare Resource Utilization in Relapsed or Refractory Multiple Myeloma: Evidence from a Medical Record Review in FranceHuamao Mark Lin, Keith L Davis, James A Kaye, et al.
Journal of Studies on Alcohol|January 28, 2004
The costs of screening and brief intervention for risky alcohol useGary A Zarkin, Jeremy W Bray, Keith L Davis, et al.
Cancer Medicine|March 18, 2021
Overall survival, adverse events, and economic burden in patients with chronic lymphocytic leukemia receiving systemic therapy: Real-world evidence from the medicare populationRavi K Goyal, Saurabh P Nagar, Shaum M Kabadi, et al.
Clinical Breast Cancer|May 21, 2019
Treatment Patterns and Outcomes Associated With Palbociclib Plus Letrozole for Postmenopausal Women With HR<sup>+</sup>/HER2<sup>-</sup> Advanced Breast Cancer Enrolled in an Expanded Access ProgramAdam Brufsky, Debanjali Mitra, Keith L Davis, et al.
The Journal of Behavioral Health Services & Research|July 13, 2005
Mental health and substance abuse treatment utilization among individuals served by multiple public agencies in 3 statesJeremy W Bray, Keith L Davis, Linda Graver, et al.
BMC Health Services Research|November 14, 2014
Comparison of demographics, treatment patterns, health care utilization, and costs among elderly patients with extensive-stage small cell and metastatic non-small cell lung cancersSudeep J Karve, Gregory L Price, Keith L Davis, et al.
Medical Care|January 17, 2007
The effect of screening and brief intervention for risky drinking on health care utilization in managed care organizationsJeremy W Bray, Gary A Zarkin, Keith L Davis, et al.
Pageof 9